The deadliest Ebola outbreak in a generation has now killed more than 2,000 people in the Democratic Republic of Congo, and an infectious disease expert says the average American does not need to worry about catching it here at home.
The numbers are staggering. Government data show 4,381 confirmed Ebola cases in eastern and northeastern Congo, with the death toll climbing past 2,000 in what health officials describe as the fastest-growing outbreak on record. The virus responsible, the rare Bundibugyo strain, has no approved vaccine and no proven treatment, leaving health workers and entire communities with almost no medical tools to fight back.
David Wohl, a professor of medicine in the Division of Infectious Diseases at the University of North Carolina at Chapel Hill, told Fox News Digital the outbreak's speed sets it apart from anything in modern memory.
"Compared to previous outbreaks, the pace at which this is moving is unprecedented."
Wohl said the outbreak is concentrated in densely populated areas of the DRC, not small villages where containment might be manageable. The scale of the affected population compounds every challenge.
"There's a lot of people who live there. So this is not breaking out in a town of 50, but in rural cities of hundreds of thousands."
The Bundibugyo strain is a different beast from the Zaire strain that ravaged West Africa in 2014. During that earlier crisis, treatments and vaccines were successfully deployed. None of those tools work against the current strain. Researchers are evaluating novel therapeutics in clinical trials and leveraging mRNA technology to develop targeted vaccines, but nothing is approved or available on the ground today.
That gap between the science and the crisis is costing lives. The New York Post reported the case fatality rate stands at 45.9 percent, higher than the 39.6 percent recorded during the 2014, 2016 West Africa outbreak that ultimately killed more than 11,000 people. The current outbreak doubled its death toll in just three weeks.
Dr. Mohamed Yakub Janabi, the WHO Regional Director for Africa, put it bluntly. He described responders as "chasing the virus" and admitted "the virus is ahead of us."
Armed conflict in the region makes a dire situation worse. Wohl noted that violence and instability block health teams from reaching affected areas.
"There's conflict in and around these areas, which makes getting in and out of them... really tough."
Community resistance is another obstacle. Robert Ndjalonga, a civil protection leader in Ituri province, told Breitbart that "the biggest challenge remains resistance from, or outright refusal by, some communities to accept response teams." Distrust of outside health workers and, in some cases, outright violence against them have slowed every containment effort.
Jean Kaseya, the Africa CDC Director-General, warned in stark terms that the window for action is closing.
"The Ebola outbreak is escalating at an alarming pace. We must act now. If we do not stop it today, this will become the worst outbreak the world has ever documented."
As if conflict and community distrust were not enough, the response is also being undermined from within. AP News reported that health workers at Bunia General Hospital and an Ebola treatment center in Rwampara went on strike over unpaid salaries. The walkouts come at a moment when the medical system can least afford them.
Dr. Chikwe Ihekweazu, the WHO emergencies chief, said many of the newly reported deaths involve people who died in their own communities "without ever reaching a health facility and without receiving care." At least 80 percent of new cases are emerging from unknown chains of transmission, and patient zero has never been identified.
The pattern is grim and familiar: an overstretched system, underpaid frontline workers, and a virus that spreads fastest where institutions are weakest. Recent revelations about U.S.-funded bio-labs operating abroad have only intensified questions about whether American public health infrastructure is prepared for biological threats originating overseas.
Dr. Jean-Marie Akandabo, a physician at an Ituri clinic, urged the public not to grow complacent. "We must not take this disease lightly, because it continues to kill and no one is safe," he said.
For all the devastation in central Africa, Wohl was direct about the threat to Americans: it is low. Ebola requires close physical contact with the bodily fluids of a severely ill or deceased person. It does not spread through the air like influenza or COVID-19.
"This is not something that I think the average person has to worry about acquiring here in the United States."
Wohl pointed to the fundamental differences between American and Congolese public health systems.
"We just have so much better public health, healthcare systems, hygiene, access. It's a very different environment."
History supports that assessment. During the 2014 West Africa outbreak, which infected more than 28,000 people, only four Ebola cases were diagnosed on American soil, according to CDC data. Two were imported cases. Two were nurses in Dallas who contracted the virus while caring for an infected patient. Several patients who were infected and diagnosed overseas were medically evacuated to the United States for treatment.
Still, the WHO and CDC are monitoring the DRC region closely. The ongoing debates over public health transparency in the wake of COVID-era controversies have made Americans understandably skeptical of official reassurances. Trust, once broken, is hard to rebuild, and the public health establishment has spent the last several years burning through its credibility.
Wohl himself did not sugarcoat the global picture. He described the DRC outbreak in terms that leave little room for optimism about what is happening on the ground thousands of miles away.
"This is a fire that's raging that continues to be out of control."
He added that more can be done. "There's lots of people suffering... and I think more can be done," Wohl said. The question is whether international institutions, many of which have spent recent years focused on political priorities rather than core missions, are capable of delivering the kind of rapid, effective response this crisis demands.
Congressional efforts to hold public health officials accountable for past failures have underscored a broader erosion of confidence in the agencies Americans are supposed to rely on during exactly these kinds of emergencies.
The 2014 outbreak eventually produced vaccines and treatments, but only for the Zaire strain. The Bundibugyo strain now ravaging the DRC has no such toolkit. Approved Ebola therapeutics have not been established as effective against Bundibugyo-related disease. Researchers are working on mRNA-based vaccines, but development timelines remain unclear.
Meanwhile, the outbreak has already spread across borders. Earlier cases crossed into Uganda, raising the prospect of wider regional transmission. The current geographic scope beyond Uganda remains an open question.
Wohl described the trajectory in blunt terms.
"The slope is just so catastrophic, with more and more people getting infected at a very significant pace without much slowing down."
For Americans watching from a distance, Wohl offered a simple bottom line: "The average person who gets a headache or a fever does not need to worry about Ebola." The virus does not travel through the air. It requires direct contact with infected bodily fluids. The United States has the infrastructure, hygiene standards, and health systems to prevent the kind of community spread devastating the DRC.
That reassurance is grounded in fact, but it also depends on institutions doing their jobs. And in an era when health crises can strike anyone, including those at the highest levels of government, Americans have every reason to demand that public health agencies stay focused on preparedness rather than politics.
Two thousand dead and counting, with no vaccine in sight. The DRC outbreak is a reminder that when institutions fail the people who depend on them most, the cost is measured in lives, and that competence, not ideology, is what stops a plague.